Indoleamine 2, 3-dioxygenase 1 (EV-IDO1) is a rate-limiting metabolic enzyme highly expressed in a variety of human cancers, although its functional effects in different cancer types are complex and remain to be investigated in relation to prognosis (92). Here, IDO1 is linked to cancer.